Evidence map›Paper›PMID 33388404›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2021

Practicing With Uncertainty: Kidney Transplantation During the COVID-19 Pandemic.

Krista L Lentine, Roslyn B Mannon, Michelle A Josephson

Open access · bronzeAbstract readReview
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Disasters and kidney care: pitfalls and solutions.Nature reviews. Nephrology · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Issues regarding COVID-19 in kidney transplantation in the ERA of the Omicron variant: a commentary by the ERA Descartes Working Group.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. COVID-19-Associated Mortality among Kidney Transplant Recipients and Candidates in the United States.Clinical journal of the American Society of Nephrology : CJASN · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Krista L LentineDivision of Nephrology, Department of Medicine, Saint Louis University Center for Abdominal Transplantation, St. Louis, MO.
Roslyn B MannonDivision of Nephrology, Department of Medicine, University of Nebraska Medical Center and Medical Service, Nebraska-Western Iowa Veterans Affairs Medical Center, Omaha, NE.
Michelle A JosephsonSection of Nephrology, Department of Medicine, University of Chicago, Chicago, IL. Electronic address: mjosephs@medicine.bsd.uchicago.edu.
Saint Louis University · USUniversity of Chicago · USUniversity of Nebraska Medical Center · US

Funding

Living Donor Extended Time Outcomes (LETO) StudyR01DK120551 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HSU, CHI-YUAN, LENTINE, KRISTA L · 2019 to 2023
$3.9M
NIDDK NIH HHS R01 DK120551
6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic required transplant nephrologists, surgeons, and care teams to make decisions about the full spectrum of transplant program operations and clinical practices in the absence of experience or data. Initially, across the country, there was a reduction in kidney transplant procedures and a striking pause in the conduct of living donation and living-donor transplant surgeries. Aspects of candidate evaluation and follow-up rapidly converted to telehealth. Months into the pandemic, much has been learned from experiences worldwide, yet many questions remain. In this Perspective, we reflect on some of the practice decisions made by the transplant community in the initial response to the pandemic and consider lessons learned, including those related to the risks, benefits, and logistical considerations of proceeding with versus delaying deceased-donor transplantation, living donation, and living-donor transplantation during the pandemic. We review the evolution of therapeutic strategies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and their use in transplant recipients, current consensus related to immunosuppression management in infected transplant recipients, and emerging information on vaccination against SARS-CoV-2. We share our thoughts on research priorities, discuss the areas in which we are still practicing with uncertainty, and look ahead to the next phase of the pandemic response.

Indexed as

COVID-19Critical PathwaysKidney Failure, ChronicClinical Decision-MakingHumansImmunosuppression TherapyInfection ControlKidney TransplantationSARS-CoV-2TelemedicineTime-to-TreatmentTissue DonorsTransplant Recipientsallograft rejectionCoronavirus disease 2019 (COVID-19)evaluationfollow-upimmunosuppression managementkidney transplantationliving kidney donationpandemicscreeningsevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)telehealththerapeuticsvaccines

Identifiers

PMID33388404
PMCPMC7946342
OpenAlexW3114607532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.